$CPAY

Farrelly Joseph W sold $2.2M of CPAY

Farrelly Joseph W sold 5,300 shares of CORPAY, INC. (CPAY) at an average of $410.00 ($405.09–$415.03, $2.17M total) across 3 trades over 2026-08-12 to 2026-08-13.

Original reporting
SEC EDGAR · Farrelly Joseph W
Published Aug 14, 2026, 8:07 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 8:48 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CPAY
Neutral
medium confidence
Mentioned
$CPAY
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CPAYNeutralLow
01

Why it matters

A director’s open-market sale totaling $2.17M is a new, concrete datapoint for insider-trading sentiment, but it does not include any new corporate event (earnings, guidance, deal, or regulatory action).

02

Market read

Traders may briefly reassess sentiment around CPAY due to insider selling, but the disclosure alone is unlikely to drive a sustained repricing without additional company catalysts.

03

What to watch

The filing does not state a 10b5-1 plan, but it also provides no reason for the sale, so interpreting it as bearish may be overstated.

Relevance 6/10Novelty 5/10Timing: filed 2026-08-14 after-hours (SEC Form 4 disclosure)

Background

The article is an SEC Form 4 insider transaction disclosure for Corpay, Inc. (CPAY).

Company-level read

Ticker impact

$CPAYNeutralMedium confidence
Context

Director Farrelly Joseph W sold about 5,300 shares of Corpay in open-market trades totaling $2.17M, per a new Form 4 filed today.

Expected impact

Likely limited, short-lived sentiment impact; watch for follow-on insider activity or concurrent company news.

Evidence & confidence

This is a routine Form 4 open-market sale with no 10b5-1 plan stated and no accompanying operational or guidance change in the text.

Market effects

No sector-level implications disclosed; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Insider sales are often pre-planned for diversification or tax, and the article provides no evidence of negative company fundamentals.

Key entities

  • CORPAY, INC.

    Subject of the Form 4 insider sale disclosure.

  • Farrelly Joseph W

    Director who sold shares in open-market transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CPAYMed

Corpay (CPAY) Just Posted A Record Quarter, So Why The Caution?

Corpay (NYSE:CPAY) reported Q2 2026 revenue of $1.34 billion, up 21% year over year and $45 million above expectations, with cash EPS of $7.00, up 36%. The company raised full-year guidance to $5.31 billion revenue and $27.35 cash EPS midpoint, citing growth in Corporate and Vehicle Payments, plus Alpha and Avid contributions, while noting a $100 million FTC-related charge and an Epics divestiture.

$CPAYMedAI 8/10

Corpay (CPAY) Q2 2026 Earnings Call Transcript

Corpay (NYSE:CPAY) reported Q2 2026 revenues of $1.34B, up 21%, and adjusted net income per diluted share of $7.00, up 36% year over year. Management guided FY2026 revenue to $5.29B-$5.33B and adjusted EPS to $27.15-$27.55, plus FCF of about $1.8B. The quarter included a $100M FTC settlement charge and $321M in share repurchases.

$CPAYHighAI 9/10

Corpay Q2 Earnings Call Highlights

Corpay (NYSE:CPAY) raised full-year revenue guidance to $5.31B at the midpoint (+17% vs 2025) and adjusted EPS to $27.35 (+28%). Q2 results included a $45M revenue beat; guidance reflects improved macro and momentum, partly offset by an epyx sale expected to close in fall. Q3 revenue midpoint is $1.355B, adjusted EPS $7.15.

$CPAYMedAI 8/10

Corpay: Q2 Earnings Snapshot

Corpay, Inc. (CPAY) reported Q2 net income of $248.3 million, or $3.70 per share. Adjusted earnings were $7.00 per share versus a Zacks estimate of $6.60. Revenue was $1.34 billion versus $1.31 billion expected. Corpay forecast full-year earnings of $27.15 to $27.55 per share and revenue of $5.29 to $5.33 billion.